4410

507789

JAGSNPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

JAGSONPAL PHARMACEUTICALS Share Price Today

JAGSONPAL PHARMACEUTICALS is currently trading at ₹209.05, down by ₹0.2 from the previous close. The stock touched an intraday high of ₹212.49 and a low of ₹206.81 during the latest trading session. Over the past one year, JAGSONPAL PHARMACEUTICALS has delivered a loss of 7.78%, while the stock has gained 3.34% in the last one month.

JAGSONPAL PHARMACEUTICALS performance

Today’s low Today’s high
₹ 206.81 ₹ 212.49
₹ 209.26
52 week low 52 week high
₹ 155.00 ₹ 301.65
₹ 209.26
Open Price ₹ 209.82
Prev. Close ₹ 209.26
Volume (Shares) 55853.00
Total traded value ₹ 116.87
Upper Circuit ₹ 251.11
Lower Circuit ₹ 167.41
info

Investment Returns

Over 1 Month 3.34% Over 3 Months 15.99% Over 6 Months 6.63% Over 1 Year -7.78%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

JAGSONPAL PHARMACEUTICALS fundamentals


  • Market cap (Cr) 1,377.70
  • P/E Ratio (TTM) 32.56
  • Beta 0.52
  • Book Value / share 41.91
  • Return on equity 18.58%
  • EPS (TTM) 6.78
  • Dividend yield 1.91%
  • Net profit/quarter (Cr) 8.76
info icon alternate text
  • Market cap (Cr) 1,379.30
  • P/E Ratio (TTM) 31.93
  • Beta 0.45
  • Book Value / share 41.91
  • Return on equity 18.58%
  • EPS (TTM) 6.78
  • Dividend yield 1.91%
  • Net profit/quarter (Cr) 8.76
info icon alternate text

JAGSONPAL PHARMACEUTICALS Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 64.20
Operating Expense 55.61
Net Profit 8.76
Net Profit Margin (%) 13.64
Earnings Per Share (EPS) 1.25
EBITDA 14.33
Effective Tax Rate (%) 25.42
Particulars DEC 2025 (Values in Cr)
Revenue 72.95
Operating Expense 59.32
Net Profit 10.95
Net Profit Margin (%) 15.01
Earnings Per Share (EPS) 1.67
EBITDA 17.16
Effective Tax Rate (%) 24.58
Particulars SEP 2025 (Values in Cr)
Revenue 74.47
Operating Expense 60.69
Net Profit 12.57
Net Profit Margin (%) 16.87
Earnings Per Share (EPS) 1.88
EBITDA 19.47
Effective Tax Rate (%) 25.22
Particulars JUN 2025 (Values in Cr)
Revenue 75.61
Operating Expense 64.00
Net Profit 10.80
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 1.60
EBITDA 17.03
Effective Tax Rate (%) 25.22
Particulars MAR 2025 (Values in Cr)
Revenue 58.56
Operating Expense 52.41
Net Profit 6.58
Net Profit Margin (%) 11.23
Earnings Per Share (EPS) 0.98
EBITDA 11.28
Effective Tax Rate (%) 24.45
Particulars MAR 2026 (Values in Cr)
Revenue 287.23
Operating Expense 239.63
Net Profit 43.08
Net Profit Margin (%) 14.99
Earnings Per Share (EPS) 6.40
EBITDA 67.99
Effective Tax Rate (%) 25.10
Particulars MAR 2025 (Values in Cr)
Revenue 268.72
Operating Expense 226.74
Net Profit 55.36
Net Profit Margin (%) 20.60
Earnings Per Share (EPS) 8.26
EBITDA 78.94
Effective Tax Rate (%) 20.75
Particulars MAR 2024 (Values in Cr)
Revenue 208.70
Operating Expense 188.11
Net Profit 22.46
Net Profit Margin (%) 10.76
Earnings Per Share (EPS) 8.49
EBITDA 32.33
Effective Tax Rate (%) 24.80
Particulars MAR 2023 (Values in Cr)
Revenue 236.71
Operating Expense 204.18
Net Profit 26.72
Net Profit Margin (%) 11.28
Earnings Per Share (EPS) 10.20
EBITDA 36.43
Effective Tax Rate (%) 23.24
Particulars MAR 2022 (Values in Cr)
Revenue 217.58
Operating Expense 194.37
Net Profit 18.86
Net Profit Margin (%) 8.66
Earnings Per Share (EPS) 7.20
EBITDA 28.46
Effective Tax Rate (%) 29.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 36.08
ROE % 18.58
ROCE % 22.82
Total Debt to Total Equity 0.04
EBITDA Margin 22.05
Particulars MAR 2024 (Values in Cr)
Book Value / Share 70.88
ROE % 12.97
ROCE % 16.89
Total Debt to Total Equity 0.04
EBITDA Margin 15.50
Particulars MAR 2023 (Values in Cr)
Book Value / Share 60.65
ROE % 18.32
ROCE % 23.48
Total Debt to Total Equity 0.02
EBITDA Margin 15.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.68
ROE % 15.28
ROCE % 21.14
Total Debt to Total Equity 0.03
EBITDA Margin 13.08
Particulars MAR 2021 (Values in Cr)
Book Value / Share 43.55
ROE % 15.70
ROCE % 19.57
Total Debt to Total Equity 0.05
EBITDA Margin 12.49
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 128.73
Total Assets 278.26
Total Liabilities 278.26
Total Equity 239.95
Share Outstanding 6
Price to Book Ratio 5.99
Return on Assets (%) 19.89
Return on Capital (%) 23.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 147.93
Total Assets 217.07
Total Liabilities 217.07
Total Equity 187.40
Share Outstanding 2
Price to Book Ratio 3.95
Return on Assets (%) 10.34
Return on Capital (%) 11.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 114.62
Total Assets 194.94
Total Liabilities 194.94
Total Equity 158.89
Share Outstanding 2
Price to Book Ratio 4.78
Return on Assets (%) 13.70
Return on Capital (%) 16.82
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.24
Total Assets 164.22
Total Liabilities 164.22
Total Equity 132.75
Share Outstanding 2
Price to Book Ratio 6.19
Return on Assets (%) 11.48
Return on Capital (%) 14.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 60.22
Total Assets 164.20
Total Liabilities 164.20
Total Equity 121.92
Share Outstanding 2
Price to Book Ratio 1.83
Return on Assets (%) 10.38
Return on Capital (%) 13.25
Particulars MAR 2025 (Values in Cr)
Net Income 69.85
Cash from Operations 63.44
Cash from Investing -45.14
Cash from Financing -11.69
Net change in Cash -1.54
Free Cash Flow 63.79
Particulars MAR 2024 (Values in Cr)
Net Income 29.86
Cash from Operations 43.67
Cash from Investing -24.54
Cash from Financing -8.91
Net change in Cash 1.70
Free Cash Flow 43.92
Particulars MAR 2023 (Values in Cr)
Net Income 34.80
Cash from Operations 53.93
Cash from Investing -57.67
Cash from Financing -0.45
Net change in Cash -11.47
Free Cash Flow 54.24
Particulars MAR 2022 (Values in Cr)
Net Income 26.64
Cash from Operations 13.78
Cash from Investing -25.77
Cash from Financing -17.55
Net change in Cash -36.41
Free Cash Flow 14.83
Particulars MAR 2021 (Values in Cr)
Net Income 21.87
Cash from Operations 31.37
Cash from Investing -2.26
Cash from Financing -6.82
Net change in Cash 19.12
Free Cash Flow 31.84
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 13.80 1.61 255.88 23.12 38.85
BLISS GVS PHARMA LTD. 439.70 35.69 3.90 4663.29 118.35 462.70
CIPLA LTD. 1381.50 29.32 3.24 111603.83 1165.55 1672.20
FERMENTA BIOTECH LTD. 328.70 14.50 2.37 967.40 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2124.65 37.41 15.87 35992.85 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.39 23.35 4.30 255.88 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 553.70 24.82 4.32 1600.78 490.00 789.95
ASTRAZENECA PHARMA IND LT 8425.15 110.03 24.13 21062.88 7630.00 10557.00
BLISS GVS PHARMA LTD. 439.70 47.43 4.03 4663.29 118.35 462.70

JAGSONPAL PHARMACEUTICALS shareholding pattern

Holding
27.87%
69.36%
2.45%
0.31%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

JAGSONPAL PHARMACEUTICALS Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
209.26 -1.80 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 209.10
  • 26 Days 205.10
  • 10 Days 207.00
  • 50 Days 201.40
  • 12 Days 206.60
  • 100 Days 198.20
  • 20 Days 205.80
  • 200 Days 201.20
213.27 PIVOT
First Support 210.63 First Resistance 215.73 Second Support 208.17 Second Resistance 218.37 Third Support 205.53 Third Resistance 220.83
RSI 61.00 ADX 12.95 MACD 1.57 Williams % R -28.31 Commodity Channel Index (CCI) 144.30
Date 2026-06-15 Week 34627.00 Same Day 33329.00 Month 46313.00
1 Year 0.53 3 Year 1.09
Over 1 Month
3.34% down
Over 1 Year
-7.78% down
Over 3 Months
15.99% down
Over 3 Years
12.88% down
Over 6 Months
6.63% down
Over 5 Years
27.90% down

JAGSONPAL PHARMACEUTICALS Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2025 2.5 Final 12 Sep 2025 Equity shares
06 Sep 2024 5.0 Final 06 Sep 2024 Equity shares
21 Aug 2023 5.0 Final 21 Aug 2023 Equity shares
29 Oct 2021 4.0 Interim 01 Nov 2021 Equity shares
22 Sep 2021 1.0 Final 24 Sep 2021 Equity shares
22 Sep 2020 0.5 Final 24 Sep 2020 Equity shares
20 Sep 2019 0.25 Final 24 Sep 2019 Equity shares
18 Sep 2018 0.1 Final 21 Sep 2018 Equity shares
21 Sep 2017 0.1 Final 23 Sep 2017 Equity shares
21 Sep 2016 0.1 Final 23 Sep 2016 Equity shares
21 Sep 2015 0.1 Final 23 Sep 2015 Equity shares
25 Sep 2014 0.5 Final 27 Sep 2014 Equity shares
25 Sep 2013 0.5 Final 27 Sep 2013 Equity shares
21 Sep 2012 5.0 Final 25 Sep 2012 Equity shares
23 Sep 2011 0.5 Final 27 Sep 2011 Equity shares
21 Sep 2010 0.5 Final 23 Sep 2010 Equity shares
23 Sep 2009 0.25 Final 25 Sep 2009 Equity shares
24 Sep 2008 0.1 Final 26 Sep 2008 Equity shares
21 Sep 2007 0.1 Final 25 Sep 2007 Equity shares
26 Sep 2005 0.0 Final 28 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
28 Jul 2004 20 Jul 2004 3:1
Ex-Date Old FV NEW FV Record Date
08 Jan 2025 5.0 2.0 08 Jan 2025
20 Jul 2004 10.0 5.0 28 Jul 2004
Dividend date Dividend amount Dividend type Record date Instrument type
12 Sep 2025 2.5 Final 12 Sep 2025 Equity shares
06 Sep 2024 5.0 Final 06 Sep 2024 Equity shares
21 Aug 2023 5.0 Final 21 Aug 2023 Equity shares
29 Oct 2021 4.0 Interim 01 Nov 2021 Equity shares
22 Sep 2021 1.0 Final 24 Sep 2021 Equity shares
22 Sep 2020 0.5 Final 24 Sep 2020 Equity shares
20 Sep 2019 0.25 Final 24 Sep 2019 Equity shares
18 Sep 2018 0.1 Final 21 Sep 2018 Equity shares
21 Sep 2017 0.1 Final 23 Sep 2017 Equity shares
21 Sep 2016 0.1 Final 23 Sep 2016 Equity shares
21 Sep 2015 0.1 Final 23 Sep 2015 Equity shares
25 Sep 2014 0.5 Final 27 Sep 2014 Equity shares
25 Sep 2013 0.5 Final 27 Sep 2013 Equity shares
21 Sep 2012 5.0 Final 25 Sep 2012 Equity shares
23 Sep 2011 0.5 Final 27 Sep 2011 Equity shares
21 Sep 2010 0.5 Final 23 Sep 2010 Equity shares
23 Sep 2009 0.25 Final 25 Sep 2009 Equity shares
24 Sep 2008 0.1 Final 26 Sep 2008 Equity shares
21 Sep 2007 0.1 Final 25 Sep 2007 Equity shares
26 Sep 2005 0.0 Final 28 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
28 Jul 2004 20 Jul 2004 3:1
Ex-Date Old FV NEW FV Record Date
08 Jan 2025 5.0 2.0 08 Jan 2025
20 Jul 2004 10.0 5.0 28 Jul 2004

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Jagsonpal Pharmaceuticals Ltd?

Answer Field

Jagsonpal Pharmaceuticals Ltd share price is for NSE ₹ 209.05 & for BSE ₹ 209.50 as on Jun 17 2026 11:06 AM.

What is the Market Cap of Jagsonpal Pharmaceuticals Ltd Share?

Answer Field

The market cap of Jagsonpal Pharmaceuticals Ltd for NSE ₹ 1,377.70 & for BSE ₹ 0.00 as on Jun 17 2026 11:06 AM.

What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd for NSE is ₹ 301.65 and ₹ 155.00 and for BSE is ₹ 301.80 and ₹ 154.90.

What is 1 year return for Jagsonpal Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -7.78%.

What is the P/E Ratio of Jagsonpal Pharmaceuticals Ltd Share?

Answer Field

As on Jun 17 2026 11:06 AM the price-to-earnings (PE) ratio for Jagsonpal Pharmaceuticals Ltd share is 32.56.

What is the PB ratio of Jagsonpal Pharmaceuticals Ltd Share?

Answer Field

As on Jun 17 2026 11:06 AM, the price-to-book (PB) ratio for Jagsonpal Pharmaceuticals Ltd share is 41.91.

How to Buy Jagsonpal Pharmaceuticals Ltd Share?

Answer Field

You can trade in Jagsonpal Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jagsonpal Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Jagsonpal Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jagsonpal Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|